Multicenter Phase II, Double-blind Placebo Controlled Tr

Project: Research project

Project Details

Description

Multicenter Phase II, Double-blind Placebo Controlled Trial of Maintenance Ixazomib after Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Multiple Myeloma (CTN1302)
StatusFinished
Effective start/end date8/17/152/28/19

Funding

  • National Marrow Donor Program

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.